CC BY
123
Thio Derivatives of 2(5H)-Furanone As Inhibitors against Bacillus subtilis Biofilms
E. Yu. Trizna1*, E. N. Khakimullina1, L. Z. Latypova1, A. R. Kurbangalieva1, I. S. Sharafutdinov1, V. G. Evtyugin1, E. V. Babynin1, M. I. Bogachev2, A. R. Kayumov1
1Kazan (Volga Region) Federal University, Kremlevskaya Str., 18, 420008, Kazan, Russia
2St. Petersburg State Electrotechnical University, Prof. Popova Str., 5, 197376, St. Petersburg,
Russia
*E-mail: [email protected]
Received 18.11.2014
Revised manuscript received 09.02.2015
Copyright © 2015 Park-media, Ltd. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT Gram-positive bacteria cause a wide spectrum of infectious diseases, including nosocomial infections. While in the biofilm, bacteria exhibit increased resistance to antibiotics and the human immune system, causing difficulties in treatment. Thus, the development of biofilm formation inhibitors is a great challenge in pharmacology. The gram-positive bacterium Bacillus subtilis is widely used as a model organism for studying biofilm formation. Here, we report on the effect of new synthesized 2(5H)-furanones on the biofilm formation by B.subtilis cells. Among 57 compounds tested, sulfur-containing derivatives of 2(5H)-furanone (F12, F15, and F94) repressed biofilm formation at a concentration of 10 ^.g/ml. Derivatives F12 and F94 were found to inhibit the biosynthesis of GFP from the promoter of the eps operon encoding genes of the biofilm exopolysaccharide synthesis (EPS). Using the differential fluorescence staining of alive/dead cells, we demonstrated an increased bacterial sensitivity to antibiotics (kanamycin and chloramphenicol) in the presence of F12, F15, and F94, with F12 being the most efficient one. The derivative F15 was capable of disrupting an already formed biofilm and thereby increasing the efficiency of antibiotics.
KEYWORDS antibacterial activity, biofilms; 2(5H)-furanones; Bacillus subtilis.
ABBREVIATIONS MIC - minimum inhibitory concentration; MBIC - minimum biofilm inhibitory concentration.
INTRODUCTION
It has now been established that in nature most bacteria exist in the form of specifically organized biofilms. Biofilms are a community of differentiated microbial cells tightly adhered to a substrate that are embedded in a polysaccharide matrix (EPS). This form of existence provides bacteria with a series of advantages under the influence of negative environmental factors and of the host organism. This leads, on one hand, to an increased efficiency of biotechnological processes and, on the other hand, to enhanced resistance to antimicrobial agents, antiseptics and disinfectants, and refractoriness to treatment, which results in an increased incidence of nosocomial infections and creates difficulties in microbiological diagnostics of infectious diseases [1 — 3]. Therefore, biofilms represent a serious problem and require the development of drugs that disrupt bacterial biofilms and inhibit their formation on medical devices. Bacilli, gram-positive spore-forming rods, e.g., Bacillus anthracis and Bacillus cereus, which cause anthrax and severe foodborne toxicoinfections, also form biofilms on
various surfaces [1]. B. subtilis cells are widely used as a model for studying bacillus biofilms [1].
Nowadays, bacterial biofilms are treated by coating surfaces with silver particles, immobilized enzymes disrupting the biofilm matrix, as well as various low-molecular weight substances that act as inhibitors of biofilm formation genes [4]. Among these substances, a special place belongs to compounds of the 2(5H)-fu-ranone series [5] that were firstly isolated from the red alga Delisea pulchra. Furanone derivatives have been shown to possess antimicrobial activity against a great number of gram-positive and gram-negative bacteria and inhibit biofilm formation [5, 6].
EXPERIMENTAL
Furanones
Figure 1 depicts the structures of the studied compounds: F12 - 5-hydroxy-4-[(4-methylphenyl)sulfo-nyl]-3-chloro-2(5H)-furanone [7], F15 - 4-benzyl-sul-fonyl-5-hydroxy-3-chloro-2(5H)-furanone [8], and
/V
Fig. 1. Structures of furanones that inhibit B.subtilis biofilm formation at a concentration of 10 pg/ml
Table 1. Minimum furanone concentrations inhibiting B.subtilis 168 growth and biofilm formation; cyto- and genotoxic properties of the compounds
Furanone Minimum inhibitory concentration (MIC), Mg/ml Minimum biofilm inhibitory concentration (MBIC), Mg/ml CC for MCF-7 50 cells, Mg/ml Genotoxicity of compounds (excess over the control, times/cell number)
Ames test* SOS chromotest*
F12 25 10 36.9 2.4 (109 ± 25.2) 0.69
F15 25 10 65.7 3.1 (133 ± 25.4) 0.61
F94 50 10 83.9 0.9 (41 ± 4.4) 1.09
Control** - - - 1.0 (45 ± 3.5) 1.00
Positive control*** - - - 8.2 (369 ± 15.6) 22.71
*Genotoxicity was evaluated at a 10 ^g/ml concentration of furanones (corresponds to their MBIC values). **Amount of dimethyl sulfoxide added in the form of a furanone solution.
***Sodium azide (3 ^g/ml) and mytomycin C (0.1 ^g/ml) were used in the Ames test and SOS chromotest, respectively. Table 2. The effect of furanones on the thickness of a B. subtilis biofilm
Furanone Biofilm thickness, Mm
Cultivation with preliminary added furanones, 96 h ' Addition of furanones to the formed biofilm with further incubation for 24 h
Control 10 ± 1.6 10 ± 1.3
F12 4 ± 0.4 6 ± 0.3
F15 2 ± 0.3 4 ± 0.2
F94 4 ± 0.6 8 ± 0.7
F94 - 1,3-bis[3-chloro-5-(1,3-dichloropropane-2-ylox-y)-2(5H)-furanone-4-ylsulfonyl]propane [9]; the compounds were synthesized according to the known techniques.
Strains and culture conditions
The following strains were used in the study: B. subtilis 168 [10]; B. subtilis K511 [11] carrying the gfp gene under the control of the promoter of the epsA gene, which is active during biofilm formation in B.subtilis.
The strains Salmonella typhimurium TA100 (HisG46, rfa, uvr-, pkm 101, bio-) [12] and S. typhimu-
rium TA1535/pSK1002 [13] were used to test the compounds for mutagenicity.
All the bacterial strains were maintained and cultured in a LB medium (1.0 g/L of tripton; 0.5 g/L of yeast extract; 0.5 g/L of NaCl; pH 8.5) [14]. Biofilm formation was determined using a BM medium (Basal medium), which is a modified SMM medium [15] supplemented with peptone to a final concentration of 7 g/L.
Biofilm staining with crystal violet
Biofilm formation was assessed in 96-well plastic plates (Cellstar Grenier bio-one No. 655 180) by stain-
ing with crystal violet. Bacteria were cultured in BM at 37 0C without shaking in wells containing 200 ^l of the bacterial culture with an initial density of 3 x 107 CFU/ml. After 72 h of incubation, the culture liquid was removed and the plates were washed once with phosphate-buffered saline (PBS) pH 7.4 and dried for 20 min. Then, 150 of a 0.1% crystal violet solution (Sigma-Aldrich) in 96% ethanol was added per well and the plates were further incubated for 20 min. The unbounded dye was washed off with PBS. The bound dye was eluted in 150 ^l of 96% ethanol, and the absorbance at 570 nm was measured on a Tecan Infinite 200 Pro microplate reader (Switzerland). Cell-free wells that were subjected to all staining manipulations were used as a control.
Determination of the minimum inhibitory concentration
The minimum inhibitory concentration (MIC) of fura-nones was determined by broth microdilution method in the BM medium in 96-well plastic plates. The concentrations of furanones after serial dilutions were in the range of 0.1-500 |^g/The wells were seeded with 200 ml of the bacterial culture (3 x 107 CFU/ml) in the BM medium and incubated at 37 °C. The minimum inhibitory concentration was determined as the lowest concentration of furanone for which no visible bacterial growth was observed after 24 h of incubation. The minimum biofilm inhibitory concentration (MBIC) was determined as the lowest concentration of furanone that completely inhibited biofilm formation after 72 h of growth.
Determination of the geno- and cytotoxicity of furanones
The mutagenicity of furanones at the MBIC concentration was evaluated in the Ames test [12]. We used the dimethyl sulfoxide (DMSO) solvent as a negative control and sodium azide (NaN3) as a positive control. A tested compound was considered to be mutagenic if the number of revertant colonies in the experiment was more than 2 times higher than that in the control (solvent). The DNA-damaging activity of the compounds was evaluated in the SOS chromotest using the S. ty-phimurium TA1535/pSK1002 strain [13]. The overnight bacterial culture was diluted 10 times with a LB medium and grown in the presence of the study compounds for 4 h. Next, the cells were collected by centri-fuging and the P-galactosidase activity was determined according to [16]. Cytotoxicity of the compounds was determined using the MTS test (Promega) on MCF-7 cells, and the median cytotoxicity concentration CC50 (the concentration required to reduce cell activity by 50%) was calculated.
Fig. 2. The effect of furanones on the fluorescence intensity of GFP expressed from the eps operon promoter in B. subtilis K511 cells. Cells were grown in the presence of F12 (B), F15 (C), and F94 (D) at a concentration of 10 ^g/ml (corresponds to MBIC) for 72 h. Cells grown in the absence of furanones were used as a control (A). The scale bar is 10
B
C
D
G F15 N ^jV ^ ' 1 ____ i 1 * H F15+Cm TV; . \ I F15+Km < * t.. J\ $ * 0 > 1 ^
J F94 / - / v 4 i s ~ K F94+Cm .sAtiÊÊr- ->#v. - 1. L F94+Km ^ v-> i \
Fig. 3. The effect of furanones on biofilm formation by B.subtilis cells and the sensitivity of B.subtilis cells adhered to the culture plate surface to antibiotics. B.subtilis 168 cells were grown for 72 h to form a biofilm in the absence (A, B, C) or presence of furanones (D, G, J) at a concentration of 10 l^g/ml (corresponds to MBIC). Then, chloramphenicol (Cm) (E, H, K) or kanamy-cin (Km) (F, I, L) was added. After 24 h of incubation with an antibiotic, the number of viable cells was analyzed by staining the cells with propidium iodide and fluorescein diacetate. The scale bar is 10
RESULTS AND DISCUSSION
Earlier, we identified halogen- and sulfur-containing derivatives of 2(5H)-furanone that inhibited B. subtilis biofilm formation [6]. Additional screening of 56 substances enabled the identification of two more furanones (F15 and F94) inhibiting the biofilm formation at a concentration of 10 Hg/ml (Table 1). F2 and F8 (5-hydroxy-4-[(4-methyl-phenyl)sulfonyl]-3-chloro-2(5H)-furanone and 3,4-di-chloro-5-[(1,3-dichloropropane-2-yloxy)]-2(5H)-fura-none, respectively), which were characterized in reference [6], increased the activity of the genetic competence system of B. subtilis and were not included in further research. F15 and F94 did not increase the activity of the transcription factor ComA, which activates the system of genetic competence development in Bacilli (not shown).
In order to establish the influence of furanones on the expression level of the eps operon encoding biofilm EPS synthesis genes, B. subtilis K511 cells carrying the gfp gene under control of the epsA gene
promoter were grown in a BM medium in the presence/absence of furanones for 72 h and analyzed using a fluorescent microscope (Fig. 2). Detection of GFP in the cells in the absence of furanones indicated expression of the eps operon and production of EPS, which is the biofilm matrix basis (Fig. 2A). GFP was not identified in the presence of furanones F12 and F94, suggesting the repression of EPS production and, as a consequence, the repression of biolfilm formation in the presence of these compounds (Fig. 2B, D). Apparently, the molecular targets for these compounds are the regulatory pathways of organism adaptation to stress conditions. Indeed, F12 was demonstrated to inhibit the activity of the transcription factors SpoOA and TnrA [6]. On the contrary, GFP was also detected in the presence of F15, although in substantially lower amounts compared to the control; therefore, no suppression of the eps operon occurred. It is possible that F15 inhibits the biofilm formation through a different pathway, without involvement of the eps operon regulation.
Control B
B Cm
E F12+Cm
H F15+Cm
K F94+Cm
Fig. 4. Furanones disrupt a biofilm and increase the efficiency of antibiotics against biofilm-embedded B.subtilis cells. B.sub-tilis cells were cultured for 72 h to form a biofilm (A, B, C). Then, fura-nones were added to a final concentration of 30 |ig/ml (threefold excess of MBIC) (D, G, J) in the presence of chloramphenicol (Cm) (E, H, K) or kanamycin (Km) (F, I, L). After 24 h of incubation with an antibiotic, the number of viable cells was analyzed by staining the cells with propidium iodide and fluorescein diace-tate. The scale bar is 10 |m
Furanones increase the sensitivity of adhered cells to antibiotics
Antimicrobial agents are known to be ineffective against bacteria in the biofilm mode of existence. Presumably, the repression of biofilm formation should increase the efficiency of antimicrobial agents. Potential synergism between furanones and antibiotics was studied using the chessboard method, where the fura-none and antibiotic (kanamycin and chloramphenicol) concentrations were varied from 0.1 to 2.0 MIC [17]. However, no compound exhibited synergism with antimicrobial agents with respect to plankton cells (FIC = 1.2 ± 0.21).
In order to investigate whether furanones increase the sensitivity of surface-adhered bacteria to antibiotics, Bacilli were grown in a BM medium in the presence of furanones at a 10 |g/ml concentration (MBIC) for 72 h, then antibiotics (chloramphenicol and kanamy-cin) were added to a final concentration of 10 |g/ml (established MIC values were 2.5 |g/ml). After 24 h of cultivation, the culture liquid was removed, the biofilm
was washed once with PBS, and differential fluorescent staining with propidium iodide and fluorescein di-acetate was performed to identify dead and alive cells, respectively, in the layer of microbial cells adhered to the culture plate surface. The obtained specimens were analyzed using a Carl Zeiss Axio Imager 2.0 fluorescent microscope (Fig. 3).
The formation of a biofilm up to 10 |m thick was observed in the control sample (Fig. 3A, Table 2). In this case, addition of chloramphenicol (Fig. 3B) or ka-namycin (Fig. 3C) resulted in the death of only a small fraction of the adhered cells. In contrast, in the culture grown in the presence of F15 (10 |im/ml), the biofilm thickness was 2 |im, and addition of an antibiotic resulted in almost complete death of bacilli (Fig. 3H, I), while furanone itself had no bactericidal effect (Fig. 3G). In case of F12 and F94 at the concentration of 10 |g/ml, the effect was less pronounced. Thus, the presence of furanones in the culture medium inhibited biofilm formation on the culture dish surface and increased the efficiency of the antibiotics, apparently due
Km
D
G
J
to a longer exposure of bacterial cells to antimicrobial agents.
The possibility of bacterial biofilm disruption in the presence of furanones was also studied. For this purpose, we grew B. subtilis cells in a BM medium for 72 h, removed the culture liquid, and added a pure BM medium supplemented with furanones (30 |^g/ml), ka-namycin, and chloramphenicol. After 24 h, the residual biofilm was washed with PBS and differential fluorescent staining was performed (Fig. 4).
As in the previous experiment, antibiotics in the absence of furanones were found to be ineffective against the cells embedded in the biofilm matrix (Fig. 4B, C). Supplementation with F12 (30 ^g/ml) caused significant biofilm disruption after 24 h (Table 2), and addition of antibiotics caused the death of the vast majority of cells (Fig. 4D—F). In this case, the effect of F15 was less pronounced, while F94 caused almost no increase in the sensitivity of the cells to the antibiotics and did not lead to biofilm disruption (Fig. 3G-L).
Cyto- and genotoxic properties of compounds F12, F15, and F94
Determination of the cytotoxicity of F12, F15, and F94 showed that their CC50 values were 7 times higher than the concentrations necessary to inhibit biofilm formation (Table 1). Although the SOS chromotest did not
detect the DNA damaging activity of the compounds, the Ames test data indicated potential mutagenicity of F12 and F15.
CONCLUSIONS
Thus, the thio-containing compounds F12 and F15 may be of interest for further development of fura-none-based inhibitors of bacterial biofilms. However, the potential mutagenicity of these furanones revealed in the Ames test serves as a contraindication for their direct application and requires further modification of their structure. •
The research was performed using the equipment of Interdisciplinary center for collective use of Kazan Federal University supported by Ministry of Education of Russia (ID RFMEFI59414X0003)
This work was supported by the Governmental Program on Improvement of Competitiveness of the Kazan (Volga Region) Federal University among the world's leading research and education centers, the Ministry of Education and Science of the Russian Federation (contract № 2014/187), and by the Russian Foundation for Basic Research (grant № 14-04-31635 mol_a).
REFERENCES
1. Vlamakis H., Chai, Y., Beauregard P., Losick R., Kolter R. // Nat. Rev. Microbiol. 2013. № 11. P. 15-168.
2. Kayumov A.R., Balaban N.P., Mardanova A.M., Kostrov S.V., Sharipova M.R. // Microbiology. 2006. V. 75. № 5.
P. 557-563.
3. Schmidt T., Ziganshin A.M., Nikolausz M., Scholwin F., Nelles M., Kleinsteuber S., Pröter J. // Biomass Bioenergy. 2014. V. 69. P. 241-248.
4. Ma Y., Xu Y., Yestrepsky B.D., Sorenson R.J., Chen M., Larsen S.D., Sun H. // PLoS One. 2012. P. 1-10.
5. Lonn-Stensrud J., Landin M.A., Benneche T., Petersen F.C., Scheiel A.A. // J. Antimicrobial Chemotherapy. 2009. № 63. P. 309-316.
6. Kayumov A.R., Khakimullina E., Sharafutdinov I., Trizna E., Latypova L., Hoang L., Margulis A., Bogachev M., Kurbangalieva A. // J. Antibiotics. 2014. № 143. doi:10.1038/ ja.2014.143 (epub ahead of print)
7. Kurbangalieva A.R., Devyatova N.F., Bogdanov A.V., Berdnikov E.A., Mannafov T.G., Krivolapov D.B., Litvinov I.A., Chmutova G.A. // Phosphorus, Sulfur, Silicon, Relat. Elem. 2007. V. 182. № 3. P. 607-630.
8. Latypova L.Z., Saygitbatalova E.Sh., Chulakova D.R., Lodochnikova O.A., Kurbangalieva A.R., Berdnikov E.A.,
Chmutova G.A. // Rus. J. Org. Chem. 2014. V. 50. Is. 4. P. 532-545.
9. Khoang T.L., Khaziev R.M., Zaripova A.R., Kurbangalieva A.R., Chmutova G.A. // Book of Abstracts of the III All-Russian Scientific Conference "Progress in Synthesis and Complex Formation". Moscow, April 21-25, 2014. Moscow: RUDN, 2014. P. 205.
10. Kayumov A., Heinrich A., Sharipova M., Iljinskaya O., Forchhammer K. // Microbiology. 2008. V. 154. P. 23482355.
11. Kobayashi K. // Mol. Microbiol. 2008. № 69. P. 1399-1410.
12. Ames B.N., McCann J. // Ann. N.Y. Acad. Sci. 1976. № 271. P. 5-13.
13. Oda Y., Nakamura S., Oki I., Kato T., Shinagawa H. // Mutat Res. 1985. № 147. P. 219-229.
14. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A laboratory manual. N.Y.: Cold Spring Harbor Lab. Press, 1989. P. 4-16.
15. Kayumov A., Heinrich A., Sharipova M., Iljinskaya O., Forchhammer K. // Microbiology. 2008. V. 154. P. 2348-2355.
16. Fedorova K., Kayumov A., Woyda K., Ilinskaja O., Forchhammer K. // FEBS Lett. 2013. V. 587. P. 1293-1298.
17. Prichard M.N., Jr. Shipman C. // Antiviral Res. 1990. № 14. P. 181-206.
